TruthArchive.ai - Related Video Feed

I recently experienced a situation where a paper was reviewed by a high-profile journal, and a reviewer requested a BSL-three experiment without the author's knowledge. This highlights the pressure to publish at all costs, even if it means conducting risky experiments. I raised concerns with the journal editor, but it seemed they were unaware of the potential dangers. This incident serves as a warning about the dangers of prioritizing publication over safety. Be cautious of this trend.

Research on potential pandemic pathogens, known as gain of function studies, has led to valuable public health insights. Previous NSABB reports support this. While I won't argue for the necessity of this research, there are many freely available studies showing how mutations identified through these studies have helped us prepare for epidemics and pandemics.

During a discussion, the speaker expresses surprise that there is a lack of information on vaccinated hospitalizations, ICU visits, and deaths at a national level. The other speaker agrees, acknowledging the challenges in data collection and the importance of providing complete information to the public. The first speaker then mentions the extensive paperwork they have to fill out for patients but notes that data on vaccinated patients and the effectiveness of hospitalizations, ICUs, and deaths was not collected. The second speaker clarifies that while they were looking at that information for vaccine effectiveness studies, they did not receive aggregated data on vaccination and hospitalizations. They emphasize the need for accurate data reporting.

I've lost faith in the journals. When we first identified the virus with six insertions, we thought it was crucial information for vaccine development. We submitted our findings, but they were ignored by various journals, including Nature and The Lancet, which claimed it wasn't in the public interest to publish our paper. Despite the scientific validity, they didn't engage with us for evidence. Molecular biologists suggested it could be random mutation, but that wasn't the case. Eventually, a biophysics journal published our work, recognizing that the alterations in charge and infectivity wouldn't occur through normal evolution. We presented our findings, but there was no willingness for further discussion.

It is nearly impossible to publish data that goes against the national public health narrative, preventing doctors from finding solutions. The speaker has conducted clinical trials for pharmaceutical companies, including vaccine studies, and has brought vaccines and other drugs to market. Some drugs never made it to market because they killed people. Clinical trial guidelines ensure safe drugs, but these guidelines were not followed during the pandemic, affecting everyone. COVID should have been a time for doctors to unite, but interference with research occurred. Science evolves through experiments, skepticism, and an open mind. Challenging current knowledge must be allowed to move science forward, but what the speaker witnessed during the pandemic was not science.

There is evidence suggesting that the Chinese Communist Party leaked the virus from a laboratory in Wuhan. They hid the truth about person-to-person transmission, which hindered our response. The Chinese Communist Party continues to conduct risky research, even using American funds. We recently discovered they are working on a COVID virus that affects the brain. We need a moratorium on this type of research. Witnesses who could provide information have mysteriously died, and the Chinese Communist Party has removed DNA sequences that could prove our theory. We must prevent future situations by stopping gain of function research and not aiding our enemies. The scientific community in China collaborates with the military and the CCP, posing a serious threat to us.

Scientists are working with dangerous pathogens to find cures, but accidents are common. Incidents like holes in protective gear, escaped infected animals, and missing pathogens have occurred. Even top labs are not immune to safety breaches. Lab accidents can lead to outbreaks, like SARS and foot and mouth disease. Despite safety measures, accidents happen regularly, mostly affecting lab workers. While rare, lab accidents can have public health consequences. Outbreaks linked to labs, like a reemerging flu strain, highlight the importance of lab safety.

A US health official working for Dr. Fauci expressed safety concerns about a lab in Wuhan, China, six years ago. The lab was planning to reverse engineer the Ebola virus, but the official was ordered to delete any mention of Ebola in her report. The lab, which is believed by some to be the source of COVID-19, was visited by the official just before it opened. During the tour, a technician at the lab mentioned the illegal importation of Ebola for study. The official expressed shock and worry about the potential consequences if this information became public. Two days later, she was instructed to delete her comment.

BioNTech's studies lacked clear guidance and evaluation of results from contract laboratories. The reproductive toxicology studies on pregnant animals showed side effects were dismissed as unimportant or already seen in control populations. This lack of seriousness in safety strategy was concerning.

You need to know the risk profile for products like the COVID vaccine. Many discuss adverse effects, but we lack sufficient data, which is unacceptable. Our surveillance system doesn't work. In 2010, the CDC had the Vaccine Adverse Event Reporting System, meant to detect injuries. However, a CDC study revealed it captures less than 1% of vaccine injuries. This is inexcusable. Congress, the Institute of Medicine, and the National Academy of Sciences have repeatedly directed the CDC to develop a better vaccine surveillance system. We will require it and address it immediately.

Many journal policies were created during a time of biosecurity focus, neglecting population-level biosafety concerns. Transparency in the approval process is important, with the public having a right to know. If openness leads to disapproval, it raises questions about why approval was granted in secret.

In 2014, a gain of function moratorium was implemented in the US due to lab accidents. Despite this, gain of function research continued in China with funding from Dr. Fauci. The NIH lifted the moratorium in 2017 without proper consultation. There are concerns that US-funded research at the Wuhan Institute of Virology may have led to the COVID-19 pandemic. Dr. Ebright believes that lapses in oversight of this research could have caused the pandemic and may lead to future ones.

I don't think there's been transparency. Routine announcements are being made about findings, and questions are being invited daily. But providing data for the evidence that is being presented isn't happening. The White House has provided information, but these claims seem to be dismissed. Information is being provided; it just isn't believed.

The data hasn't been shared because the virus wasn't isolated. Live animal samples testing positive don't provide useful information. It seems the source of the virus is not what we initially believed.

The data hasn't been shared because the virus wasn't isolated. Testing live animal samples doesn't provide useful information if they only show positive results. I don't believe the virus originated from what we initially thought.

When the virus emerged, scientists were alarmed and held secret calls questioning its origin. Despite privately suspecting a lab origin, they published a paper claiming it was natural. This cover-up at Nature Medicine has not been retracted. The government has not been transparent, with information coming from whistleblowers and Freedom of Information Act requests.

A key insight from the report is the failure to transition from an initial precautionary approach during the pandemic to a more evidence-based strategy that considered risks, benefits, and non-health impacts. This lack of shift has significant implications for public trust. The report highlights insufficient transparency regarding the rationale and evidence behind government decisions that affected Australians' lives and freedoms. Consequently, trust has declined significantly compared to pre-pandemic levels. The panel indicates that many measures implemented during COVID-19 are unlikely to be accepted by the public in the future due to these issues.

The Pfizer COVID vaccine was not tested for its ability to stop the transmission of the virus before it entered the market. The speaker acknowledges that they had to work quickly to understand the situation and move at the speed of science.

A key insight from the report is the failure to transition from an initial precautionary approach during the pandemic to a more evidence-based strategy that balanced risks and benefits, including non-health impacts. This lack of shift has significant implications for public trust. The report highlights insufficient transparency regarding the rationale and evidence behind government decisions, which deeply affected Australians' lives and freedoms. As a result, trust has declined compared to pre-pandemic levels. The panel warns that many measures implemented during COVID-19 are unlikely to be accepted by the public in the future due to this erosion of trust.

We had a study on highway threats that was classified but got denied last minute because it wouldn't pass the New York Times test. Public affairs thought it could be misinterpreted as offensive bioweapons work. Despite its potential to help biosecurity, it was shelved. Most government work, even classified, is transparent.

Many countries lack proper safety monitoring systems for vaccines, leading to miscommunication and confusion. Adjuvants are necessary for vaccine effectiveness, but can increase adverse reactions. Long-term effects and cross-reactivity between adjuvants are concerns. Health professionals are starting to question vaccine safety due to lack of confidence and education.

There was a lack of transparency about vaccine side effects, leading to underreporting. Mandating vaccines was a mistake; personal choice should have been allowed since they don't prevent infection and have side effects. Translation: Lack of transparency and underreporting of side effects, along with mandating vaccines, were mistakes. Personal choice should have been allowed due to the vaccines not preventing infection and having side effects.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

There are leaks almost every week in BSL 3 and BSL 4 labs, and no lab is immune. The executive order aims to prevent inadvertent leaks and protect humanity. The COVID outbreak cost twenty million lives and at least $25 trillion. The COVID nightmare was likely preventable, and the leading theory is that it came from the Wuhan Lab, which was five miles from the initial outbreak. The speaker believes the outbreak was the result of scientists manipulating nature in a lab using technology exported from the United States, specifically inserting a furin cleavage site. The speaker hopes the executive order will do some good.

My understanding of the PC30 framework is that it focuses on a small number of viruses with both pathogenicity and transmissibility. However, there are discrepancies in the criteria used, leading to unintended studies being included. More refinement may be needed to ensure accurate submissions. The definition on paper may not always align with real-world practices.